Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Core EBITDA Growth

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 18.3121.3829.11-12.9944.86

What is the latest Core EBITDA Growth ratio of CONCORD BIOTECH ?

The latest Core EBITDA Growth ratio of CONCORD BIOTECH is 18.31 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202518.31
Mar202421.38
Mar202329.11
Mar2022-12.99
Mar202144.86

How is Core EBITDA Growth of CONCORD BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2025 18.31
-14.36
Mar2024 21.38
-26.55
Mar2023 29.11
Positive
Mar2022 -12.99
Negative
Mar2021 44.86 -

Other Financial Ratios of CONCORD BIOTECH


Compare Core EBITDA Growth ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹15,239.7 Cr 0.1% -8.9% -18.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,147.0 Cr -1.4% 3.6% -7.8% Stock Analytics
DIVIS LABORATORIES ₹180,488.0 Cr 4.4% 15.9% 15.6% Stock Analytics
CIPLA ₹121,452.0 Cr -4.9% -0.8% 6.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,057.0 Cr -0.6% 1.8% 15.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,220.0 Cr -4.1% -3.8% -4.3% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

0.1%

-8.9%

-18.8%

SENSEX

-1.4%

3.1%

3.8%


You may also like the below Video Courses